1. Home
  2. INSE vs SGMT Comparison

INSE vs SGMT Comparison

Compare INSE & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

HOLD

Current Price

$6.57

Market Cap

179.5M

Sector

Technology

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$7.75

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSE
SGMT
Founded
2002
2006
Country
United States
United States
Employees
1020
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
179.5M
169.4M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
INSE
SGMT
Price
$6.57
$7.75
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$14.00
$26.13
AVG Volume (30 Days)
144.4K
1.4M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$199,800,000.00
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.25
N/A
52 Week Low
$6.11
$4.50
52 Week High
$9.95
$11.41

Technical Indicators

Market Signals
Indicator
INSE
SGMT
Relative Strength Index (RSI) 32.66 58.62
Support Level $6.29 $7.04
Resistance Level $8.57 $8.80
Average True Range (ATR) 0.43 0.50
MACD -0.13 0.03
Stochastic Oscillator 4.76 74.60

Price Performance

Historical Comparison
INSE
SGMT

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: